10 articles2,285 citations
Histotype-Tailored Neoadjuvant Chemotherapy versus Standard Chemotherapy in Patients with High-Risk Soft-Tissue Sarcomas (ISG-STS 1001): An International, Open-Label, Randomised, Controlled, Phase 3, Multicentre Trial.Citation only
Gronchi, Casali·Lancet Oncol·2017·500 citations
Long-Term Outcome for Patients with Nonmetastatic Osteosarcoma of the Extremity Treated at the Istituto Ortopedico Rizzoli According to the Istituto Ortopedico Rizzoli/osteosarcoma-2 Protocol: An Updated Report
Bacci, Campanacci·JCO·2000·449 citations
Chemotherapy-Induced Tumor Necrosis as a Prognostic Factor in Localized Ewing's Sarcoma of the Extremities.Citation only
Picci, Bertoni·J Clin Oncol·1997·263 citations
Neoadjuvant Chemotherapy for Osteosarcoma of the Extremities with Metastases at Presentation: Recent Experience at the Rizzoli Institute in 57 Patients Treated with Cisplatin, Doxorubicin, and a High Dose of Methotrexate and Ifosfamide.Citation only
Bacci, Galletti·Ann Oncol·2003·190 citations
Surgical Downstaging in an Open-Label Phase II Trial of Denosumab in Patients with Giant Cell Tumor of Bone.Citation only
Rutkowski, Bach·Ann Surg Oncol·2015·189 citations
Mesenchymal Chondrosarcoma: Prognostic Factors and Outcome in 113 Patients. A European Musculoskeletal Oncology Society Study.Citation only
Frezza, Whelan·Eur J Cancer·2015·180 citations
Neoadjuvant Chemotherapy for Osteosarcoma of the ExtremityCitation only
Bacci, DePaolis·Eur J Cancer·2001·172 citations
Osteosarcoma of the Limb
Bacci, Pignotti·J Bone Joint Surg Br·2002·170 citations
Tenosynovial Giant Cell Tumour/pigmented Villonodular Synovitis: Outcome of 294 Patients before the Era of Kinase Inhibitors.Citation only
Palmerini, Stacchiotti·Eur J Cancer·2015·144 citations
Angiosarcoma of Bone: A Retrospective Study of the European Musculoskeletal Oncology Society (EMSOS).Citation only
Palmerini, Ferrari·Sci Rep·2020·28 citations